T/SRMA 36-2024 Chronic Coronary Artery Syndrome Enhancement External Counterpulsation Therapy Application Guideline

Scope

Scope: This document provides guidelines for the standardized application of enhanced extracorporeal counterpulsation (EECP) in patients with chronic coronary syndrome, including contraindications, treatment process, treatment duration and course, treatment of patients with other concomitant diseases, and hierarchical diagnosis and treatment of patients. This document is applicable to medical personnel engaged in the diagnosis and treatment of cardiovascular diseases in all levels of medical institutions for the EECP treatment of patients with chronic coronary syndrome. Main technical content: Standardized treatment process: The guidelines provide standardized recommendations for the clinical pathway, technical specifications, hierarchical diagnosis and treatment, and referral process of EECP in the treatment of CCS, aiming to improve the effectiveness and safety of treatment. Clarify treatment indications and contraindications: The guidelines list in detail the types of CCS patients suitable for EECP treatment, as well as situations in which EECP treatment is not appropriate, such as moderate to severe aortic valve insufficiency and various hemorrhagic diseases, helping doctors to more accurately determine the treatment plan. Improve treatment effect: EECP treatment has been proven to significantly improve coronary artery blood flow, treat stable angina pectoris, and increase the coronary artery blood flow reserve and exercise tolerance in patients with refractory angina pectoris, thereby improving patients' angina pectoris symptoms and quality of life. Patient safety and comfort: The guidelines emphasize the importance of conducting safety assessments on patients during EECP treatment and ensuring that patients have a full understanding of the treatment efficacy and risks, thereby enhancing the safety of treatment and improving patient comfort.

Development Information

Related Standards